Literature DB >> 2683798

Immunoreactivity for IL-1 beta and TNF alpha in human lymphoid and nonlymphoid tissues.

L P Ruco1, A Stoppacciaro, D Pomponi, D Boraschi, A Santoni, A Tagliabue, S Uccini, C D Baroni.   

Abstract

Monoclonal antibodies (MAbs) against two non-cross-reacting antigens of human IL-1 beta (Vhp20 and BRhC3) and human TNF alpha (B154.2 and B154.7) were applied to identify cytokine-containing cells in tissue sections and in cell suspensions. IL-1 beta- or TNF alpha-positive cells were not present in immunostained cytocentrifuge smears prepared from freshly isolated peripheral blood leukocytes, spleen, and lymph node cells. After 18 hours of culture with bacterial endotoxin (LPS), 80% to 90% of blood monocytes, 30% of spleen macrophages, and 2% to 28% of lymph node macrophages were strongly positive for IL-1 beta with either of the MAbs. Furthermore, 25% to 35% of blood monocytes and 6% to 60% of lymph node macrophages were stained for TNF alpha. Cells positive for IL-1 beta or TNF alpha were extremely rare in sections of normal thymus, spleen, and lymph nodes. Immunoreactivity for IL-1 beta or TNF alpha was frequently observed in sections of granulomatous lymphadenitis (N = 11). IL-1 beta or TNF alpha staining was confined to the epithelioid macrophages forming the granuloma, and the intensity of TNF alpha reactivity was generally stronger. The high frequency of cytokine-containing cells in this pathologic condition was confirmed in a cell suspension study showing that 20% of epithelioid macrophages were weakly positive for IL-1 beta and 80% were strongly positive for TNF alpha. The presence of cytokine-containing cells was investigated in cryostat sections of several nonlymphoid organs with normal histologic appearance. IL-1 beta reactivity was not observed in any of the tissues. TNF alpha reactivity was frequently demonstrated in isolated macrophages embedded in the interstitial connective tissue.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2683798      PMCID: PMC1880100     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  21 in total

1.  Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.

Authors:  L P Ruco; M S Meltzer
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

2.  Interleukin-1-like immunoreactivity in peripheral tissues.

Authors:  M Schultzberg; S B Svenson; A Unden; T Bartfai
Journal:  J Neurosci Res       Date:  1987       Impact factor: 4.164

Review 3.  The common mediator of shock, cachexia, and tumor necrosis.

Authors:  B Beutler; A Cerami
Journal:  Adv Immunol       Date:  1988       Impact factor: 3.543

4.  Potentiation of cultured mouse thymocyte responses by factors released by peripheral leucocytes.

Authors:  I Gery; R K Gershon; B H Waksman
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

5.  Genes for IFN-beta-2 (IL-6), tumor necrosis factor, and IL-1 are expressed at high levels in the organs of normal individuals.

Authors:  M G Tovey; J Content; I Gresser; J Gugenheim; B Blanchard; J Guymarho; P Poupart; M Gigou; A Shaw; W Fiers
Journal:  J Immunol       Date:  1988-11-01       Impact factor: 5.422

6.  Detection of IL-1 alpha and IL-1 beta gene expression by in situ hybridization. Tissue localization of IL-1 mRNA in the normal C57BL/6 mouse.

Authors:  L Takács; E J Kovacs; M R Smith; H A Young; S K Durum
Journal:  J Immunol       Date:  1988-11-01       Impact factor: 5.422

7.  Production of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor by human mononuclear cells stimulated with granulocyte-macrophage colony-stimulating factor.

Authors:  S D Sisson; C A Dinarello
Journal:  Blood       Date:  1988-10       Impact factor: 22.113

8.  Immunohistochemical analysis of sarcoid granulomas. Evaluation of Ki67+ and interleukin-1+ cells.

Authors:  M Chilosi; F Menestrina; P Capelli; L Montagna; M Lestani; G Pizzolo; A Cipriani; C Agostini; L Trentin; R Zambello
Journal:  Am J Pathol       Date:  1988-05       Impact factor: 4.307

9.  Demonstration by in situ hybridization of dissimilar IL-1 beta gene expression in human alveolar macrophages and blood monocytes in response to lipopolysaccharide.

Authors:  J F Bernaudin; K Yamauchi; M D Wewers; M J Tocci; V J Ferrans; R G Crystal
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

10.  Interferon gamma and lipopolysaccharide promote macrophage adherence to basement membrane glycoproteins.

Authors:  L M Shaw; A M Mercurio
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more
  11 in total

1.  The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours.

Authors:  M G Luciani; A Stoppacciaro; G Peri; A Mantovani; L P Ruco
Journal:  Mol Pathol       Date:  1998-10

2.  A novel lipopolysaccharide-induced transcription factor regulating tumor necrosis factor alpha gene expression: molecular cloning, sequencing, characterization, and chromosomal assignment.

Authors:  F Myokai; S Takashiba; R Lebo; S Amar
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

3.  Tumor necrosis factor receptors in lymphoid tissues and lymphomas. Source and site of action of tumor necrosis factor alpha.

Authors:  B Ryffel; M Brockhaus; U Dürmüller; F Gudat
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

4.  Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.

Authors:  N Di Girolamo; A Lloyd; P McCluskey; M Filipic; D Wakefield
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

5.  Tumour necrosis factor receptor distribution in human lymphoid tissue.

Authors:  B Ryffel; M Brockhaus; B Greiner; M J Mihatsch; F Gudat
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

6.  Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.

Authors:  L P Ruco; D Pomponi; R Pigott; A Stoppacciaro; F Monardo; S Uccini; D Boraschi; A Tagliabue; A Santoni; E Dejana
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

7.  Detection of endogenous cytokines in sera or in lymph nodes obtained from patients with sarcoidosis.

Authors:  M Asano; T Minagawa; M Ohmichi; Y Hiraga
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

8.  Immunohistochemical detection of co-localizing cytokine and antibody producing cells in the extrafollicular area of human palatine tonsils.

Authors:  S Hoefakker; E H van 't Erve; C Deen; A J van den Eertwegh; W J Boersma; W R Notten; E Claassen
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

9.  The cytokines NAP-1 (IL-8), MCP-1, IL-1 beta, and GRO in rabbit inflammatory skin lesions produced by the chemical irritant sulfur mustard.

Authors:  J Tsuruta; K Sugisaki; A M Dannenberg; T Yoshimura; Y Abe; P Mounts
Journal:  Inflammation       Date:  1996-06       Impact factor: 4.092

10.  Soluble intercellular adhesion molecule-1 (ICAM-1) in sera and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis.

Authors:  N Shijubo; K Imai; K Shigehara; Y Honda; H Koba; M Tsujisaki; Y Hinoda; A Yachi; M Ohmichi; Y Hiraga
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.